Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Lähdeaho, Marja Leena ^a   Mäki, Markku ^a   Laurila, Kaija ^a   Huhtala, Heini ^a   Kaukinen, Katri ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD3+ T LYMPHOCYTE; CELIAC DISEASE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DIETARY INTAKE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE MUCOSA; MALE; MUCOSA INFLAMMATION; SEROCONVERSION; SEROLOGY; SMALL INTESTINE DISEASE; ANTIBODY PRODUCTION; BIOPSY; BLOOD; COHORT ANALYSIS; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PILOT STUDY; SMALL INTESTINE;

ANTIBODY; AUTOANTIBODY; GLUTEN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ADULT; AGED; ANTIBODIES; ANTIBODY FORMATION; AUTOANTIBODIES; BIOPSY; CELIAC DISEASE; COHORT STUDIES; ENTERITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTENS; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; PILOT PROJECTS; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 82055171829     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-129     Document Type: Article

References (40)

1. Rostom A, Murray JA, Kagnoff MF. The American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1981-2002. 10.1053/j.gastro.2006.10.004, 17087937.
2. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990, 65:909-11. 1792502, 2205160.
3. Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 1995, 9:273-93. 10.1016/0950-3528(95)90032-2, 7549028.
4. MacDonald WC, Brandborg LL, Flick AL, Trier JS, Rubin CE. Studies of celiac disease sprue. IV. The response of whole length of the small bowel to a gluten-free diet. Gastroenterology 1964, 47:573-89.
5. Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008, 6:186-93. 10.1016/j.cgh.2007.10.012, 2577378, 18096440.
6. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002, 346:180-8. 10.1056/NEJMra010852, 11796853.
7. McNeish AS, Harms HK, Rey J, Shmerling DH, Visakorpi JK, Walker-Smith JA. The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1979, 54:783-6. 10.1136/adc.54.10.783, 1545649, 507902.
8. Holm K, Mäki M, Vuolteenaho N, et al. Oats in the treatment of chilhood coeliac disease: a two-year controlled and a long-term clinical follow-up study. Aliment Pharmacol Ther 2006, 23:1463-72. 10.1111/j.1365-2036.2006.02908.x, 16669961.
9. Mäki M, Lähdeaho ML, Hällström O, Viander M, Visakorpi JK. Postpubertal gluten challenge in coeliac disease. Arch Dis Child 1989, 64:1604-7. 10.1136/adc.64.11.1604, 1792633, 2604420.
10. van Overbeek FM, Uil-Dieterman IG, Mol IW, Kohler-Brands L, Heymans HS, Mulder CJ. The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur J Gastroenterol Hepatol 1997, 9:1097-9.
11. Kumar PJ, Walker-Smith J, Milla P, Harris G, Colyer J, Halliday R. The teenage coeliac: follow up study of 102 patients. Arch Dis Child 1988, 63:916-20. 10.1136/adc.63.8.916, 1779000, 3415327.
12. Montgomery AM, Goka AK, Kumar PJ, Farthing MJ, Clark ML. Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies. Gut 1988, 29:1564-8. 10.1136/gut.29.11.1564, 1433820, 3209114.
13. Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 2007, 85:160-6.
14. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009, 30:315-30. 10.1111/j.1365-2036.2009.04053.x, 19485977.
15. Collin P, Thorell L, Kaukinen K, Mäki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease?. Aliment Pharmacol Ther 2004, 19:1277-83. 10.1111/j.1365-2036.2004.01961.x, 15191509.
16. Hischenhuber C, Crevel R, Jarry B, et al. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 2006, 23:559-75. 10.1111/j.1365-2036.2006.02768.x, 16480395.
17. Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med 2011, 269:604-13. 10.1111/j.1365-2796.2011.02376.x, 21401739.
18. Aziz I, Evans KE, Papageorgiou V, Sanders DS. Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?. J Gastrointestin Liver Dis 2011, 20:27-31.
19. Kuitunen P, Kosnai I, Savilahti E. Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr 1982, 1:525-31. 10.1097/00005176-198212000-00012, 7186067.
20. Kaukinen K, Peräaho M, Collin P, et al. Small bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized study. Scand J Gastroenterol 2005, 40:564-572. 10.1080/00365520510023422, 16036509.
21. Järvinen TT, Kaukinen K, Laurila K, et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 2003, 98:1332-7. 10.1111/j.1572-0241.2003.07456.x, 12818278.
22. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998, 115:1322-8. 10.1016/S0016-5085(98)70008-3, 9834257.
23. Korponay-Szabo IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004, 53:641-8. 10.1136/gut.2003.024836, 1774023, 15082580.
24. Salmi TT, Collin P, Korponay-Szabo I, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 2006, 55:1746-53. 10.1136/gut.2005.071514, 1856451, 16571636.
25. Shiner M, Ballard J. Antigen-antibody reactions in jejunal mucosa in childhood coeliac disease after gluten challenge. Lancet 1972, 1:1202-5.
26. Kaukinen K, Collin P, Holm K, et al. Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 1999, 34:164-169.
27. Sturgess R, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994, 343:758-61. 10.1016/S0140-6736(94)91837-6, 7907731.
28. Kaukinen K, Turjanmaa K, Mäki M, et al. Intolerance to cereals is not specific for coeliac disease. Scand J Gastroenterol 2000, 35:942-6. 10.1080/003655200750022995, 11063153.
29. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003, 348:2517-24. 10.1056/NEJMoa021687, 12815137.
30. Kaukinen K, Peräaho M, Lindfors K, et al. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther 2007, 25:1237-45. 10.1111/j.1365-2036.2007.03311.x, 17451570.
31. Rubio-Tapia A, Rahim MW, See JA, Lahr BD, Wu TT, Murray JA. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010, 105:1412-20. 10.1038/ajg.2010.10, 2881171, 20145607.
32. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000, 95:712-4. 10.1111/j.1572-0241.2000.01838.x, 10710062.
33. Troncone R, Mayer M, Spagnuolo F, Maiuri L, Greco L. Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr 1995, 21:69-72. 10.1097/00005176-199507000-00012, 8576818.
34. Salmi TT, Collin P, Järvinen O, et al. Immunoglobin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006, 24:541-52. 10.1111/j.1365-2036.2006.02997.x, 16886921.
35. Högberg L, Stenhammar L, Wagermark J. Very late mucosal relapse in a girl with coeliac disease. Acta Paediatr 1993, 82:887-9.
36. Matysiak-Budnik T, Malamut G, Patey-Mariaud de Serre N, et al. Long-term follow-up of 61 patients diagnosed in childhood:evolution towards latency is possible on a normal diet. Gut 2007, 56:1379-86. 10.1136/gut.2006.100511, 2000276, 17303598.
37. Kurppa K, Koskinen O, Collin P, et al. Changing phenotype of celiac disease after long-term gluten exposure. J Pediatr Gastroenterol Nutr 2008, 47:500-3. 10.1097/MPG.0b013e31817d8120, 18852644.
38. Bardella MT, Velio P, Cesana BM, et al. Coeliac disease: a histological follow-up study. Histopathology 2007, 50:465-71. 10.1111/j.1365-2559.2007.02621.x, 17448022.
39. Lee SK, Lo W, Memeo L, Rotterdam H, Green PHR. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003, 57:187-91. 10.1067/mge.2003.54, 12556782.
40. Lanzini A, Lanzarotto F, Villanacci V, et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009, 29:1299-308. 10.1111/j.1365-2036.2009.03992.x, 19302264.